These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20151390)

  • 1. Easy production of a glycolipid analogue using animal cells in culture.
    Kasuya MC; Hatanaka K
    Chem Biodivers; 2010 Feb; 7(2):440-6. PubMed ID: 20151390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorous-tagged compound: a viable scaffold to prime oligosaccharide synthesis by cellular enzymes.
    Kasuya MC; Cusi R; Ishihara O; Miyagawa A; Hashimoto K; Sato T; Hatanaka K
    Biochem Biophys Res Commun; 2004 Apr; 316(3):599-604. PubMed ID: 15033442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient sialylation on azidododecyl lactosides by using B16 melanoma cells.
    Murozuka Y; Kasuya MC; Kobayashi M; Watanabe Y; Sato T; Hatanaka K
    Chem Biodivers; 2005 Aug; 2(8):1063-78. PubMed ID: 17193190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aglycon structure on saccharide elongation by cells.
    Kimura T; Kasuya MC; Hatanaka K; Matsuoka K
    Chem Biodivers; 2015 Feb; 12(2):239-47. PubMed ID: 25676505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of new glycosylation methodologies for the synthesis of archaeal-derived glycolipid adjuvants.
    Whitfield DM; Yu SH; Dicaire CJ; Sprott GD
    Carbohydr Res; 2010 Jan; 345(2):214-29. PubMed ID: 20004891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel method for chase analysis of oligosaccharide metabolic error caused by xenobiotics.
    Kato T; Muraoka M; Hatanaka K
    Anal Biochem; 2010 Oct; 405(1):103-8. PubMed ID: 20570645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficient and stereoselective synthesis of beta-glycolipids.
    Morales-Serna JA; Boutureira O; Díaz Y; Matheu MI; Castillón S
    Org Biomol Chem; 2008 Feb; 6(3):443-6. PubMed ID: 18219410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis-associated murine melanoma cell surface galactosyltransferase: characterization of enzyme activity and identification of the major surface substrates.
    Passaniti A; Hart GW
    Cancer Res; 1990 Nov; 50(22):7261-71. PubMed ID: 2121334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of lactosylceramide analogs in animal cells: amphipathic disaccharide primers for glycosphingolipid synthesis.
    Miura Y; Yamagata T
    Biochem Biophys Res Commun; 1997 Dec; 241(3):698-703. PubMed ID: 9434771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Had-1, a uridine 5'-diphosphogalactose transport-defective mutant of mouse mammary tumor cell FM3A: composition of glycolipids, cell growth inhibition by lactosylceramide, and loss of tumorigenicity.
    Taki T; Ogura K; Rokukawa C; Hara T; Kawakita M; Endo T; Kobata A; Handa S
    Cancer Res; 1991 Mar; 51(6):1701-7. PubMed ID: 1998961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convenient synthesis of the immunogenic glycolipid BbGL1.
    Jäger SN; Porta EOJ; Labadie GR
    Steroids; 2019 Jan; 141():41-45. PubMed ID: 30468783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azido glycoside primer: a versatile building block for the biocombinatorial synthesis of glycosphingolipid analogues.
    Kasuya MC; Wang LX; Lee YC; Mitsuki M; Nakajima H; Miura Y; Sato T; Hatanaka K; Yamagata S; Yamagata T
    Carbohydr Res; 2000 Dec; 329(4):755-63. PubMed ID: 11125817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses of an alpha-D-Gal-(1-->6)-beta-D-Gal diglyceride, as lipase substrate.
    Lafont D; Carrière F; Ferrato F; Boullanger P
    Carbohydr Res; 2006 May; 341(6):695-704. PubMed ID: 16458274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loading of the antigen-presenting protein CD1d with synthetic glycolipids.
    Wallner FK; Chen L; Moliner A; Jondal M; Elofsson M
    Chembiochem; 2004 Apr; 5(4):437-44. PubMed ID: 15185366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the NEO strategy (Nucleophilic addition/Epoxide Opening) for the synthesis of a new C-galactoside ester analogue of KRN 7000.
    Banchet-Cadeddu A; Martinez A; Guillarme S; Parietti V; Monneaux F; Hénon E; Renault JH; Nuzillard JM; Haudrechy A
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2510-4. PubMed ID: 21392982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-step synthesis of the immunogenic bacterial glycolipid BbGL1.
    Kulkarni SS; Gervay-Hague J
    Org Lett; 2008 Nov; 10(21):4739-42. PubMed ID: 18798644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of glycolipids in the Golgi complex.
    Maccioni HJ
    J Neurochem; 2007 Nov; 103 Suppl 1():81-90. PubMed ID: 17986143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells.
    Inokuchi J; Momosaki K; Shimeno H; Nagamatsu A; Radin NS
    J Cell Physiol; 1989 Dec; 141(3):573-83. PubMed ID: 2531751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of glycolipid in development, cell growth regulation, and transformation.
    Hakomori S
    Prog Clin Biol Res; 1980; 41():873-86. PubMed ID: 7454732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.